- [PRESSWIRE] Parma – 12 September, 2018 — A study, which has been published in NDT [1] today shows that caffeine consumption is associated with a lower mortality rate in CKD patients. This relationship has already been observed in the general population. Although this study shows that this association may persist if caffeine is consumed through caffeine-containing soft drinks, the president of the European Renal Nutrition Working Group, Professor Denis Fouque, recommends CKD patients not to consume these soft drinks, but to drink coffee or tea instead.
- [PRESSWIRE] Parma – 06 August, 2018 — New NDT study [1] shows that `normal´ pre-dialysis blood pressure measurement is not reliable. “Without performing extended ambulatory BP recordings (44h – 48h) we approvingly accept an error rate of about 30% in the diagnosis of hypertension in dialysis patients, a highly vulnerable patient group with a dramatically elevated cardiovascular risk. This is why EURECA-m recommends ambulatory blood pressure monitoring as gold standard for the diagnosis for hypertension in hemodialysis patient.”
- [PRESSWIRE] Parma – 29 June, 2018 — The ERA-EDTA and the Japanese Society of Nephrology (JSN) are delighted to announce continuing progress in their joint collaboration in the important field of mineral and bone disorder in chronic kidney disease (CKD-MBD). This serious condition affects most people as their kidney disease progresses.
- [PRESSWIRE] Copenhagen, Denmark – 24 May, 2018 — ERA-EDTA Congress 2018 sees the launch of the ADPKD Patient Route Map, an interactive resource designed to help educate and empower people affected by autosomal dominant polycystic kidney disease (ADPKD).
- [PRESSWIRE] PALO ALTO, California, May 18, 2018 — ReCor Medical announced today that it will present the primary outcomes data from the SOLO study of its RADIANCE Global Clinical Trial Program of the Paradise® Ultrasound Renal Denervation System for patients with hypertension during the Late Breaker Sessions at the EuroPCR 2018 Meeting in Paris on 23 May.
- [PRESSWIRE] SHANGHAI, CAMBRIDGE, Massachusetts and REYKJAVIK, Iceland, April 26, 2018 — WuXi NextCODE, the global standard platform for genomic data, today detailed its plans and progress in building a pioneering global network to improve the diagnosis and treatment of rare disease.
- [PRESSWIRE] London, United Kingdom – 17.03.15 — A recent compelling study published in the journal Molecular Cancer Therapeutics adds to the growing evidence that marijuana possesses medical properties and should be legally available for medicinal purposes.